Airbnb … Testing its Reversal

October 17, 2026 By in ABN26-07, ABNB, ABNB-26-06, David Weis, Real Estate 4 Comments

Wide, High-Volume Bar(s)

Nearly twenty years ago, David Weis said in his training video:

‘Wide, high-volume bars, tend to be tested’

Now, twenty years later, we see that exact thing happening with Airbnb.

On August 7th, this year, ABNB launched 17.43%, with twice normal volume after an earnings release; links here and here.

So, we have a ‘wide, high-volume bar’.

What’s most likely to happen next?

Airbnb ABNB, Daily

What’s most likely, is the wide bar gets tested.

If we know that wide bars tend to get tested, then trades can be planned accordingly (not advice, not a recommendation).

After the launch phase and during the reversal, ABNB was traded profitably to the downside: ABNB-26-06, and ABNB-26-07.

With that said, what happens next, or what’s likely to happen?

We’ll cover that, in tomorrow’s update.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Reading the Tape: Biotech

October 16, 2026 By in $SPSIBI, Biotech, SPBIO, Wyckoff, Wyckoff Stock Market Institute, XBI, XBI-26-24 Leave a comment

Once You See It.

Legend has it, Wyckoff locked himself in a room with nothing but a stock ticker and telephone; working many hours to decipher what the tape was telling him.

Later, the result of that effort was presented in his seminal text, Studies In Tape Reading, first published in 1910.

One of, if not the most important concept of that effort (also in his training materials) was, ‘What’s the market saying about itself?’

We’re going to use that idea to look at the biotech sector and specifically XBI.

Biotech XBI, Daily

There it is:

We have at least three significant thrusts lower; four if you count the one on August 28th, all of which suggest that XBI is in ‘distribution’ (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Downtrend

October 15, 2026 By in $SPSIBI, Biotech, Charles Dow, Linda Raschke, SPBIO, XBI, XBI-26-24 Leave a comment

Meets the Definition

We just had a reminder days ago, from Linda Raschke, about the definition of a price action ‘trend’.

For a downtrend, it’s lower lows and lower highs.

When looking at biotech XBI, that’s what we have; a downtrend (not advice, not a recommendation).

Biotech XBI, Daily

At this point, we’re between ‘spring’ and ‘resistance’.

We see the Fibonacci sequence comes and goes; next up is ‘Day 55’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Palantir at Resistance

October 14, 2026 By in PLTR, Spring-to-Up-Thrust Leave a comment

Reversal?

We have a Fibonacci sequence and a repeating pattern (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Qualcomm Channel

October 13, 2026 By in QCOM, Semiconductors Leave a comment

Reverse Trendline

The segment at left, shows the ‘reverse trendline’ technique in action.

The left side trendline was drawn first (days ago), then brought forward to the most recent high (at No. 1).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna’s ‘Measured Move’

October 12, 2026 By in $SPSIBI, Biotech, DIA, Dow 30, Financial Sector, IBB, IYR, MRNA, Nasdaq, Real Estate, S&P, S&P 500, SOXX, SPBIO, XBI, XLF, XLV Leave a comment

From Resistance To Wedge … and Back?

The last update on Moderna, here, said that price action had slammed into resistance.

The chart shows that MRNA, has gone from resistance. to wedge, to measured move.

With the S&P and Qs, stalled at all-time highs, SOXX, DIA, XLF, IYR well off their highs with the biotech sector in an apparent reversal, one has to wonder what’s next (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

SOXX at Support

October 11, 2026 By in NVDA, Semiconductors, SOXX, TSM, Up-Thrust Leave a comment

What’s Next?

Last week, both Nvidia and Taiwan Semi, the two largest caps in the sector, reversed from their all-time highs.

The SOXX chart shows the effect of that action.

Now, we’re at a support level (dashed line).

‘Normal’ market behavior is to come back for a test (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Top 1%

October 10, 2026 By in David Weis, Linda Raschke, Spring-to-Up-Thrust, Up-Thrust, Wyckoff 2 Comments

Raschke, Weis and Wyckoff

The late David Weis once said he kept a copy of Wyckoff’s autobiography in his office, near him.

He made notes on it and marked it up so many times, the cover had fallen off.

His website (now deactivated) had a picture of him holding an original first edition Wyckoff ‘Studies In Tape Reading‘.

The last time I checked, that edition (if you could find one) in good condition, went for around $3,500.

All of this, ties-in with a recent interview of master trader, Linda Raschke, link here.

Wyckoff is specifically mentioned at time stamp: 10:52

In fact, just a few seconds later, we have a discussion on ‘springs’ and ‘up-thrusts’. 🙂

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Quarterly Chart … XBI

October 9, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-21 Leave a comment

The Really Big Picture

One of the few indices or sectors that has not made new all-time highs, is Biotech XBI.

In the case at left, XBI spent an entire quarter pinned against resistance, going nowhere.

Now, in the first week or so of the current quarter, XBI is edging away from the highs (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

CarMax Stays in Lane

October 8, 2026 By in KMX, Transportation Leave a comment

Like Many Others

The last update on KMX, is here.

It said the retrace to 23.6%, was “exceedingly weak”.

We can see proof of that as KMX has reversed near the 23.6% retrace and is now in a downward channel (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279